11:18am ET
Health and Healthcare
With a Vaccine Coming Soon, Where Do These COVID-19 Stocks Stand?
Here is an update on the stocks of each major player in the COVID-19 arena, including brief trading histories and consensus price targets.
Companies
/Healthcare
Astrazeneca plc
$164.37
▼ $1.90 (−1.14%) today
Markets closed · 5:54pm ET
AZN Coverage
Page 5
8:56am ET
Investing
Top Analyst Upgrades and Downgrades: AIG, CrowdStrike, Datadog, Devon Energy, eGain, Lyft, Moderna, Occidental, Peloton, Yelp and More
Wednesday's top analyst upgrades and downgrades included AIG, CrowdStrike, Datadog, Devon Energy, eGain, Lyft, Moderna, Occidental Petroleum, Peloton Interactive and Yelp.
11:09am ET
Health and Healthcare
Why the US Is Paying $486 Million to Test AstraZeneca’s COVID-19 Drug CocktailÂ
Two federal agencies have awarded AstraZeneca some $486 million to develop further the company's treatment and potential vaccine for COVID-19. The payment includes delivery of 100,000 doses of the medicine.
Paul Ausick 11:58am ET
Health and Healthcare
Where We Stand on a Vaccine After Trump Catches COVID-19
President Trump and the First Lady have tested positive for COVID-19. That begs the question, now more than ever, of where we stand with a coronavirus vaccine.
7:42am ET
Health and Healthcare
4 Companies in Late-Stage Coronavirus Vaccine Testing: Will Big Pharma Win the Race?
These companies have a very good shot at crossing the finish line first with a COVID-19 vaccine. Even those that won't also have huge product lines and robust pipelines with future drug…
10:48am ET
Investing
The Advantage Johnson & Johnson’s Phase 3 COVID-19 Study Has Over Rivals
The race for the COVID-19 vaccine is still very much on, and Johnson & Johnson just announced the launch of a Phase 3 trial.
9:26am ET
Health and Healthcare
This Week in Coronavirus News
As an approved COVID-19 vaccine nears completion in terms of clinical trials, what can we expect? In the past couple of weeks, firms working toward this goal have taken steps forward and…
3:27pm ET
Health and Healthcare
What Does a Perfect COVID-19 Vaccine Actually Mean?
The race for finding the COVID-19 vaccine is in full swing, and it has just seen one team move ahead of the others. Before getting into an actual prediction basis for knowing…
7:27pm ET
Health and Healthcare
As CDC Issues Notice, Stock Market Bets Which Company Gets First COVID-19 Vaccine FDA Approval
America and the rest of the world is getting ready for a vaccine that will help protect public health against the COVID-19 pandemic. The societal impact of the coronavirus has changed many…
8:46am ET
Health and Healthcare
3 COVID-19 Vaccine Trials Are Now in Phase 3, With More on the Way
Three U.S. COVID-19 vaccine trials are now in Phase 3 studies. All three appear to have some serious benefits, but none are approved yet.
6:31am ET
Health and Healthcare
AbbVie, Eli Lilly, Gilead, and More Biopharma Stocks Reporting Earnings This Week
Earnings season is in full swing, and we have put together a preview of some of the world’s largest players in the health care sector reporting this coming week.
7:33am ET
Health and Healthcare
5 FDA COVID-19 Decisions in July Could Make or Break Stocks
Here is a look of a few of the biggest clinical trial and FDA updates to watch for in July 2020.
2:02pm ET
Health and Healthcare
Why an Appeals Court May Hold Key to Amarin Stock Future
Amarin Corp. PLC (NASDAQ: AMRN) plans to mount a vigorous and speedy appeal of a U.S. District Court ruling that blocked its patents on the medication Vascepa, the company’s chief executive says.…
1:17pm ET
Health and Healthcare
Court Rejects Patent Protection, Crushing Amarin Stock
Until late Monday, Amarin continued to get good news relevant to Vascepa, its treatment for cardiovascular disease. The big news, though, was lurking in Nevada federal district court.
7:05am ET
Health and Healthcare
Why Big Pharmaceutical Stocks May Be the Best Place for Worried Investors Now
Some investors are looking for conservative growth ideas, and big pharma may be the ticket. These four top stocks have been hit hard, and the companies have paid dependable dividends for years.